PLASMA CONCENTRATIONS OF PHENOBARBITAL IN THE TREATMENT OF SEIZURES IN NEWBORNS

ABSTRACT: Jailing, B. (Departments of Paediatrics and Clinical Pharmacology, Karolinska Hospital, Stockholm, Sweden). Plasma concentrations of phenobarbital in the treatment of seizures in newborns. Acta Paediatr Scand, 64:514, 1975.–The plasma concentration of phenobarbital given as anticonvulsive treatment in the newborn period has been followed in 18 infants. With constant daily doses, the drug accumulated for at least 5 days. After intramuscular injection of a single dose, 90 % of the peak concentration was reached within 4 hours in 8 of the 10 infants. The peak concentration (in µg/ml) approximately equalled 1.3 × the dose (in mg/kg). Absorption after oral administration was less reliable. In 12 of the infants the clinical course allowed attempts to evaluate the anticonvulsive effect of phenobarbital. In 4 cases the convulsions continued. In those 8 infants where phenobarbital seemed to be effective, the approximate range of phenobarbital concentration when convulsions ceased was 12–30 µg/ml. Phenobarbital half‐life ranged between 59 and 182 hours. In some infants the rate of phenobarbital disappearance from the plasma varied considerably from day‐to day. The pathological conditions causing seizures probably influence the distribution, metabolism and excretion of the drug. For the often seriously ill infants with convulsions it is therefore difficult to construct rational maintenance dose schedules, and optimal dosage must be based on repeated determinations of the plasma concentration.

[1]  B. Jalling Plasma and cerebrospinal fluid concentrations of phenobarbital in infants given single doses. , 1974, Developmental medicine and child neurology.

[2]  K. Kastrup,et al.  Successful Prophylaxis of Febrile Convulsions with Phenobarbital , 1972, Epilepsia.

[3]  M. Lund Epilepsy Centres in Denmark , 1972, Epilepsia.

[4]  I. Gamstorp,et al.  80. NEONATAL SEIZURES; EFFECT OF LIDOCAIN , 1970 .

[5]  J. Freeman Neonatal seizures--diagnosis and management. , 1970, The Journal of pediatrics.

[6]  I. Gamstorp,et al.  Neonatal seizures; effect of lidocain. , 1970, Acta paediatrica Scandinavica. Supplement.

[7]  H. Ferngren Brain and blood levels of phenobarbital-2-14C during postnatal development in the mouse. , 1969, Acta pharmaceutica Suecica.

[8]  U. Keuth [Seizures in newborn infants]. , 1969, Monatsschrift fur Kinderheilkunde.

[9]  M. Rowland,et al.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. , 1968, Journal of pharmaceutical sciences.

[10]  O. Svensmark,et al.  Placental transfer of phenobarbitone in epileptic women, and elimination in newborns. , 1967, Lancet.

[11]  M. Critchley PAEDIATRIC NEUROLOGY , 1967, Developmental medicine and child neurology.

[12]  J. Schwartz Meonatology Review : Neonatal Convulsions , 1965 .

[13]  J. Schwartz Neonatal convulsions: pathogenesis, diagnostic evaluation, treatment and prognosis. , 1965, Clinical pediatrics.

[14]  L. J. Roth,et al.  An ontogenetic study of phenobarbital-C-14 in cat brain. , 1960, The Journal of pharmacology and experimental therapeutics.

[15]  T. Butler,et al.  The distribution and excretion of phenobarbital. , 1958, The Journal of clinical investigation.

[16]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.